Client Testimonials

Prestige Nursing is one of the UK's largest nursing agencies, and has specialised in the supply of temporary nursing care staff to the healthcare industry for more than 50 years. As one of the most trusted names in the industry, Prestige Nursing prides itself on delivering a high quality, personalised service through its national network of branches.

Grenville Homes has established itself as a key player within the luxury new home market by displaying a keen awareness of what today's home buyer wants. Contemporary living demands new and improved construction materials, advanced technologies and far higher internal specifications than ever before.

The directors of Grenville Homes can draw on over 100 years of experience in building highly distinctive and exclusive homes. Peter Owen, the Managing Director of the Group can himself boast over 25 years of experience in the building industry. His breadth of knowledge of the property market comes from a long and distinguished career at director level within several of the country's leading homebuilders. In forming the company Peter sought like-minded highly experienced and motivated individuals to work with him in providing uniquely designed homes for the more discerning buyer.

Cytyc Corporation, based in Boxborough, Massachusetts (USA), designs, develops, manufactures, and markets the ThinPrep® System for use in medical diagnostic applications primarily focused on women’s health.

They have implemented several growth initiatives to expand market share of the ThinPrep System, which is widely used for cervical cancer screening. Specifically, they utilized the ThinPrep System platform to launch our expansion into breast cancer risk assessment with the FirstCyte™ Breast Test.

In addition, they actively expanded their geographic reach to key international markets and continue to strengthen their global presence today. They are also continuing to evaluate new business opportunities to leverage their technology and distribution channel.

The introduction of the ThinPrep® Imaging System later this year and opportunities for expanding molecular-based diagnostic tests are two such initiatives. They believe these initiatives will continue to positively impact women’s healthcare and further Cytyc’s mission to predict and prevent disease.